Thomas Meier

Chief Executive Officer (CEO)
neurology
Santhera Pharmaceuticals
United States of America

Biography

Thomas Meier was appointed Chief Executive Officer (CEO) of Santhera in October 2011, having served for 7 years as Chief Scientific Officer (CSO) for the company. Thomas was the founder and CEO of MyoContract, a Basel-based research company focused on orphan neuromuscular diseases, which he merged with Graffinity Pharmaceuticals of Heidelberg, Germany, in 2004, to form today’s Santhera.

Research Interest

ophthalmology

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America